Isarna Therapeutics
Founded
1998
1998
Patents
10
10
Clinical Trials
4
4
Publications
8
8
Technologies
Antisense OligonucleotidesIsarna Therapeutics has an unmatched commitment to developing TGF-B inhibitors that stimulate the human immune system to effectively fight cancer. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.
Become a Member to view additional information about this company